255 — Lung Kee group Income Statement
0.000.00%
Last trade - 00:00- HK$1.00bn
- HK$417.46m
- HK$1.32bn
Annual income statement for Lung Kee group, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,273 | 1,601 | 1,449 | 1,553 | 1,320 |
| Cost of Revenue | |||||
| Gross Profit | 1,452 | 963 | 814 | 952 | 848 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,958 | 1,580 | 1,562 | 1,573 | 1,353 |
| Operating Profit | 315 | 21.7 | -113 | -19.4 | -33.1 |
| Net Income Before Taxes | 315 | 21.7 | -113 | -19.4 | -33.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 228 | 15.8 | -72.4 | -13.7 | -22.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 228 | 15.8 | -72.4 | -13.7 | -22.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 228 | 15.8 | -72.4 | -13.7 | -22.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.351 | 0.01 | -0.123 | -0.024 | -0.049 |
| Dividends per Share | |||||
| Special Dividends per Share |